Amanta Healthcare Ltd Share Price

Amanta Healthcare Limited was originally incorporated on December 21 1994 as Marck Parenterals India Limited with RoC Gujarat at Ahmedabad by converting the existing Partnership Firm Marck Parenterals India on January 06 1995. The Company name was changed to Marck Biosciences Limited vide a fresh Certificate of Incorporation issued by the Registrar of Companies Gujarat at Ahmedabad dated November 2 2005 and was again changed to Amanta Healthcare Limited dated June 24 2014. Amanta Healthcare Limited is a pharmaceutical company engaged in developing manufacturing and marketing a diverse range of sterile liquid products parenteral products packed in plastic container with Aseptic BlowFillSeal ABFS and Injection Strech Blow Moulding ISBM technology. The Company manufacture large volume parenterals LVPs and small volume parenterals SVPs in six therapeutic segments. In addition to that it also manufacturer medical devices. It manufacture fluid therapy IV Fluid formulations diluents ophthalmic respiratory care and irrigation solutions in therapeutic segment and products like irrigation firstaid solution eye lubricants etc. in medical device segment. It offer closure systems such as nipple head twistoff leurlock and screw types and container fillvolume ranging from 2ml to 1000 ml.The Company introduced Large Volume Parenterals LVP project for Formulations Fluid Therapy Irrigation Solution in year 1997 and started the L1 in Block A in 1998. It launched a specialised production line LVP Line II for the manufacture of Large Volume Parenterals in Kheda District of Gujarat in 2002. Further it launched a specialised production line SVP Line I for the manufacture of Small Volume Parenterals in Kheda Gujarat in 2005 launched LIII Large Volume Parenterals Facility for 500 ml products in Block A in 2007 launched a specialised production line SVP line II for the manufacture of Small Volume Parenterals in Gujarat in 2008. Following the approval from National Company Law Tribunal Ahmedabad in October 2018 Marck Remedies Private Limited MRPL got merged with the Company through the Scheme of Amalgamation and the entire undertaking of MRPL was transferred to the Company as a going concern effective from April 1 2017. In consideration of the transfer of MRPLs undertaking 1 fully paidup Equity Share of Rs 10 of the Company was issued and allotted for every 38 equity shares of Rs 10 each held in MRPL by their respective shareholders.Later on the Company launched a specialised production line SteriPort Debottlenecking in 2021 and is currently manufacturing out of seven 7 active production lines including SVP and LVP in 2024. The Company is planning an Initial Public Offer of upto 12500000 Equity Shares through Fresh Issue..

Revenue: ₹70.89Cr as on September 2025 (Q2 FY26)
Net Profit: ₹1.21Cr as on September 2025 (Q2 FY26)
Listing date: 09 Sep, 2025
Chairperson Name: Rohitbhai J Patel